报价延迟最少15分钟:2025/11/27 18:32 EST
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
1.59 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-0.93/-0.52
|
|
企业价值
91.92M
|
| 资产负债 |
|
每股账面净值
-1.36
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
192.35M
|
|
每股收益
6.12
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比较之报价最少15分钟延迟
|
业务概览
|
|||
| Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others. |
